Mode
Text Size
Log in / Sign up
N/A N=36 Randomized Double-blind Treatment

Bihemispheric Transcranial Direct Current Stimulation* on Speech Fluency

Stuttering, Adult

Enrolled (actual)
36
Serious AEs
0.0%
Results posted
Mar 2026
Primary outcome: Primary: Stuttered Syllables in Passage Reading (Change in the Percentage of Stuttered Syllables After 5 Days of Intervention From Baseline) — -1.41; -0.81 percentage of stuttered syllables

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Transcranial direct current stimulation (Device)
Age
Adult · 18+ yrs
Sex
All
Sponsor
Biruni University
Primary completion
Jun 2024

Outcome Measures

OutcomeResultp-value
PRIMARY
Stuttered Syllables in Passage Reading (Change in the Percentage of Stuttered Syllables After 5 Days of Intervention From Baseline)
-1.41; -0.81
PRIMARY
Stuttered Syllables in Passage Reading (Change From Baseline in Percentage of Disfluent Syllables 1 Week After Intervention)
0.86; 0.87
PRIMARY
Stuttered Syllables in Conversation (Change in the Percentage of Stuttered Syllables After 5 Days of Intervention From Baseline)
-0.40; 0.07
PRIMARY
Stuttered Syllables in Conversation (Change From Baseline in Percentage of Disfluent Syllables 1 Week After Intervention)
-0.69; 0.16
SECONDARY
Change in Stuttering Severity Instrument (SSI-IV) Scores After 5 Days of Intervention From Baseline
-1.94; -1.76
SECONDARY
Change From Baseline in Stuttering Severity Instrument (SSI-IV) Scores 1 Week After Intervention
-3.00; -2.06
SECONDARY
Change in The Overall Assessment of the Speaker's Experience of Stuttering (OASES) Scores After 5 Days of Intervention From Baseline
-15.56; -8.53
SECONDARY
Change From Baseline in The Overall Assessment of the Speaker's Experience of Stuttering (OASES) Scores 1 Week After Intervention
-14.72; -14.19

Summary

It will be determined whether bihemispheric stimulation (anodal to the left IFG and cathodal to the right IFG) is used with fluency-facilitating conditions for 5 consecutive days in individuals with stuttering and whether there is a difference in terms of the effects seen in speech fluency compared to the sham condition.

Eligibility Criteria

Inclusion Criteria

  • developmental stuttering
  • age between 18 and 60 years
  • right hand dominant

Exclusion Criteria

  • history of seizures, head trauma, hearing problems, cochlear implant, intracranial metal implantation, medications that affects the central nervous system, implanted neurostimulators, cardiac pacemakers, or medication infusion devices
  • any speech and language disorder other than developmental stuttering
  • neurological or psychiatric disorders, brain surgery, tumours, neurodevelopmental disorders, or attention deficit hyperactivity disorder
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT06278233). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search